European Pharmacopoeia to discontinue print version

European Pharmacopoeia to discontinue print version

EDQM has announced that they will launch the online-only European Pharmacopoeia (Ph.Eur.) in June 2025. They say that discontinuation of the printed version is a step towards becoming more environmentally friendly. ?A set of new features in the new online platform will improve the user experience at all levels and enable the Ph. Eur. to better meet subscribers’ needs for years to come.

Starting with issue 12.1, the Ph. Eur. will be available exclusively online, with all texts – current, pending implementation and certain previous editions of the Ph. Eur. – available to subscribers on an improved, user-friendly platform combining a modern, intuitive interface with dynamic visuals. Users will be guided seamlessly to the content they need through powerful search tools, a dashboard and new filters and attributes.

The former three-year cycle comprising one edition and eight supplements will be replaced by an annual edition made up of three issues, numbered .1 to .3 (for example, the 12th Edition will consist of issues 12.1, 12.2 and 12.3). Each of these issues will contain the new and revised texts adopted at one of the three European Pharmacopoeia Commission (EPC) sessions held annually. What will not change is the implementation schedule, which remains January, April and July, respectively, of the year following publication of a text. A detailed calendar presenting the EPC sessions and adoption and implementation dates will be published in due time.

A 365-day licence will also be introduced, with simplified licence management.

All subscriptions to the 11th Edition will remain valid during the transitional period until the end of 2025. As of 1 January 2026, users will only be able to subscribe to the online version.

?

要查看或添加评论,请登录

Peter Gough的更多文章

  • Roche QDP module 1 in SSF

    Roche QDP module 1 in SSF

    Glad to be back in South San Francisco with Peter Calcott to deliver the Pharmaceutical Law module of the Roche Quality…

    2 条评论
  • New EU Regulation 2025/40 on Packaging and Packaging waste

    New EU Regulation 2025/40 on Packaging and Packaging waste

    Regulation (EU) 2025/40 of the European Parliament and of the Council of 19 December 2024 on packaging and packaging…

    2 条评论
  • QDP module 1 at Roche

    QDP module 1 at Roche

    Great to be back in Basel with Peter Calcott to deliver module 1, Pharmaceutical Law, of the Roche Quality Development…

    3 条评论
  • 50 years in Pharma.

    50 years in Pharma.

    Today I complete 50 years working in the pharmaceutical industry. I started as an analyst in the QC laboratory of Eli…

    100 条评论
  • NSF 2024 Conference

    NSF 2024 Conference

    Very proud to have been a speaker at NSF's very successful conference on World Quality Day last week. We had some truly…

    2 条评论
  • Revision of UK CT legislation

    Revision of UK CT legislation

    The UK MHRA has communicated that the revision of the clinical trials legislation is now in progress. The amending…

    1 条评论
  • MHRA Date Strategy

    MHRA Date Strategy

    The UK MHRA has published their first ever 29 page ‘Data Strategy 2024 to 2027’ document. This outlines five strategic…

  • EMA: AI in the product lifecycle

    EMA: AI in the product lifecycle

    On 30 September 2024 the EMA published the final version of their ‘Reflection paper on the use of Artificial…

  • UK MHRA guidance for QPs and RPis following the 'Windsor Framework'

    UK MHRA guidance for QPs and RPis following the 'Windsor Framework'

    On 12 September 2024 the MHRA issued new guidance titled “Wholesalers & manufacturers guidance following agreement of…

    5 条评论
  • CDER Quantitative Medicine Center of Excellence

    CDER Quantitative Medicine Center of Excellence

    US FDA has recently launched the new CDER Quantitative Medicine (QM) Center of Excellence (CoE). The goal of this CoE…

社区洞察

其他会员也浏览了